These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30129528)

  • 1. The role of Staphylococcus lugdunensis in skin and soft tissue infections.
    García Colmenero L; Martin-Ezquerra G; Sánchez-Schmidt JM; Segura S; Pujol RM
    Eur J Dermatol; 2018 Aug; 28(4):551-553. PubMed ID: 30129528
    [No Abstract]   [Full Text] [Related]  

  • 2. Staphylococcus lugdunensis: An Emerging Pathogen in Skin and Soft Tissue Infections.
    Lozano-Masdemont B; Gómez-Recuero-Muñoz L; Pulido-Pérez A
    Actas Dermosifiliogr; 2015 Nov; 106(9):769-70. PubMed ID: 26076877
    [No Abstract]   [Full Text] [Related]  

  • 3. Skin and soft tissue infections caused by Staphylococcus lugdunensis: report of 20 cases.
    Arias M; Tena D; Apellániz M; Asensio MP; Caballero P; Hernández C; Tejedor F; Bisquert J
    Scand J Infect Dis; 2010 Dec; 42(11-12):879-84. PubMed ID: 20735327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and microbiological properties of Staphylococcus lugdunensis skin infections.
    Zaaroura H; Geffen Y; Bergman R; Avitan-Hersh E
    J Dermatol; 2018 Aug; 45(8):994-999. PubMed ID: 29897142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abscesses and wound infections due to Staphylococcus lugdunensis: report of 16 cases.
    Papapetropoulos N; Papapetropoulou M; Vantarakis A
    Infection; 2013 Apr; 41(2):525-8. PubMed ID: 23242962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulase-Negative Staphylococcus Skin and Soft Tissue Infections.
    Natsis NE; Cohen PR
    Am J Clin Dermatol; 2018 Oct; 19(5):671-677. PubMed ID: 29882122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical challenges and unmet needs in the management of complicated skin and skin structure, and soft tissue infections.
    Turina M; Cheadle WG
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-23-36. PubMed ID: 23577495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of
    Hurvitz N; Cahan LOS; Gross I; Grupel D; Megged O; Pasternak Y; Temper V; Levy R; Weiser G; Hashavya S
    J Med Microbiol; 2021 May; 70(5):. PubMed ID: 34038340
    [No Abstract]   [Full Text] [Related]  

  • 9. Caution when reconsidering empiric antimicrobial therapy for methicillin-resistant Staphylococcus aureus skin and soft-tissue infections.
    da Silva LV; Zavascki AP; de Souza MV; Marcadenti A
    Am J Surg; 2008 Oct; 196(4):618-9. PubMed ID: 18809069
    [No Abstract]   [Full Text] [Related]  

  • 10. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
    Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
    Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus: role of tigecycline.
    Curcio D
    Clin Infect Dis; 2011 Jun; 52(12):1468-9. PubMed ID: 21498390
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.
    Daum RS
    N Engl J Med; 2007 Jul; 357(4):380-90. PubMed ID: 17652653
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of skin and soft tissue infections due to community-associated methicillin-resistant Staphylococcus aureus in Europe: the role of trimethoprim-sulfamethoxazole0010.
    De Angelis G; Cipriani M; Cauda R; Tacconelli E
    Clin Infect Dis; 2011 Jun; 52(12):1471-2; author reply 1472. PubMed ID: 21628490
    [No Abstract]   [Full Text] [Related]  

  • 14. Clindamycin resistance among Staphylococcus aureus strains in Israel: implications for empirical treatment of skin and soft tissue infections.
    Stein M; Komerska J; Prizade M; Sheinberg B; Tasher D; Somekh E
    Int J Infect Dis; 2016 May; 46():18-21. PubMed ID: 26987479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcus lugdunensis in skin infections: pathogen or colonizing bacterium?
    Hubiche T; Del Giudice P; Roudière L
    J Clin Microbiol; 2009 Sep; 47(9):3057. PubMed ID: 19641062
    [No Abstract]   [Full Text] [Related]  

  • 16. Ceftobiprole: a new option for treatment of skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
    Widmer AF
    Clin Infect Dis; 2008 Mar; 46(5):656-8. PubMed ID: 18225983
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibiotics for methicillin-resistant Staphylococcus aureus skin and soft tissue infections: the challenge of outpatient therapy.
    Pate AJ; Terribilini RG; Ghobadi F; Azhir A; Barber A; Pearson JM; Kalantari H; Hassen GW
    Am J Emerg Med; 2014 Feb; 32(2):135-8. PubMed ID: 24238483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of community-acquired methicillin-resistant Staphylococcus aureus infections.
    Fergie J; Purcell K
    Pediatr Infect Dis J; 2008 Jan; 27(1):67-8. PubMed ID: 18162942
    [No Abstract]   [Full Text] [Related]  

  • 19. Staphylococcus lugdunensis, a common cause of skin and soft tissue infections in the community.
    Böcher S; Tønning B; Skov RL; Prag J
    J Clin Microbiol; 2009 Apr; 47(4):946-50. PubMed ID: 19244465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serious staphylococcal infections--cyclic lipopeptides: meeting new challenges.
    Graninger W
    Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():1-2. PubMed ID: 18226083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.